The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control
2008 ◽
Vol 82
(1)
◽
pp. 127-131
◽
2012 ◽
Vol 51
(16)
◽
pp. 2091-2096
◽
2010 ◽
Vol 339
(5)
◽
pp. 433-439
◽
2014 ◽
Vol 63
(12)
◽
pp. A1409
2007 ◽
Vol 85
(3)
◽
pp. 406-412
◽